Resource Center
Can’t find what you need? Fill out the Request Information form and a BD associate will reach out to you soon.
Reimbursement
Reimbursement Assistance
- The following Letter of Medical Necessity for the BD MAX Vaginal Panel may be helpful when drafting insurance correspondence for your patients based on their unique medical history. Download the Letter of Medical Necessity Template >>
- BD knows that reimbursement is a key part of your institution’s operation. BD has a reimbursement site for BD MAX™ available, hosted and supported by CodeMap. Please visit the site at the following link: www.codemap.com/BDMAX
Enteric Solutions
Multimedia
- BD MAX™ Extended Enteric Bacterial Panel Presentation Download Slides
- Webinar: Optimizing GI Testing: Molecular Diagnostic Testing for Common Stool Pathogens Watch on Labroots >>
Scientific Publications
- BD MAX™ Enteric Bacterial Panel | Multicenter evaluation of the BD max enteric bacterial panel PCR assay for rapid detection of Salmonella spp., Shigella spp., Campylobacter spp. (C. jejuni and C. coli), and Shiga toxin 1 and 2 genes. Access on PubMed>>
- BD MAX™ Enteric Bacterial Panel | Comparison of time-motion analysis of conventional stool culture and the BD MAX™ EntericBacterial Panel (EBP). Access on PubMed>>
- BD MAX™ Enteric Parasite Panel | Multicenter Evaluation of BD Max Enteric Parasite Real-Time PCR Assay for Detection of Giardia duodenalis, Cryptosporidium hominis, Cryptosporidium parvum, and Entamoeba histolytica. Access on PubMed>>
Whitepapers and Info Sheets
- BD MAX™ Enteric Bacterial Panel Info Sheet Download
- BD MAX™ Extended Enteric Bacterial Panel Info Sheet Download
- BD MAX™ Enteric Parasite Panel Info Sheet Download
- BD MAX™ Enteric Bacterial Panel Case Study Download
- BD MAX™ Enteric Solutions Brochure Download
Healthcare-Associated Infections
Multimedia
- Webinar: Clostridioides difficile Testing: Conundrums, Guidelines and Diagnostic Stewardship Watch on Labroots >>
Scientific Publications
- BD MAX™ Cdiff | Comparative performance study of six commercial molecular assays for rapid detection of toxigenic Clostridium difficile. Access on PubMed>>
- BD MAX™ Cdiff | Evaluation of the BD Max Cdiff assay for the detection of toxigenic Clostridium difficile in humanstool specimens. Access on PubMed>>
- BD MAX™ MRSA XT | Comparison of the BD MAX MRSA XT to the Cepheid™ Xpert® MRSA assay for the molecular detection of methicillin-resistant Staphylococcus aureus from nasal swabs. Access on PubMed>>
- BD MAX™ MRSA XT | Comparison of BD Max StaphSR and BD Max MRSAXT for Screening of Staphylococcus aureus Clinical Isolates Collected from Hospitals in the United States. Access on PubMed>>
- BD MAX™ StaphSR | Performance of BD Max StaphSR for Screening of Methicillin-Resistant Staphylococcus aureus Isolates among a Contemporary and Diverse Collection from 146 Institutions Located in Nine U.S. Census Regions: Prevalence of mecA Dropout Mutants. Access on PubMed>>
Whitepapers and Info Sheets
- BD MAX™ Healthcare-Associated Infections Info Sheet Download
BD MAX™ System
Multimedia
- Video: BD Molecular Diagnostics: Choices to Improve Outcomes Watch>>
- Video: Making Molecular Diagnostics Simple and Routine Watch>>
- Video: Providing Rapid Value-Add Results Watch>>
Whitepapers and Info Sheets
Interactive Tools
- COMING SOON: BD MAX™ Workflow Optimization Tool. Get in touch to access to the tool soon. Contact Us>>
